Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals (INO) Financial Statements


Inovio Pharmaceuticals Financial Overview

Inovio Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.533; its P/E ratio is -1.91; Inovio Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-1.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 102.70K$ 388.45K$ 225.97K$ 114.94K
Gross Profit-$ 102.65K$ 388.45K$ 225.97K$ 114.94K
EBIT$ -30.17M$ -24.72M$ -33.62M$ -35.22M$ -40.34M
EBITDA$ -29.41M$ -24.57M-$ -34.08M$ -39.18M
Net Income Common Stockholders$ -30.50M$ -25.00M$ -34.13M$ -35.50M$ -40.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 105.61M$ 145.29M$ 167.47M$ 194.93M$ 223.75M
Total Assets$ 129.11M$ 170.95M$ 193.10M$ 233.04M$ 266.58M
Total Debt$ 13.43M$ 30.21M$ 29.80M$ 30.76M$ 31.16M
Net Debt$ -92.19M$ -115.08M$ -137.67M$ -164.16M$ -192.59M
Total Liabilities$ 34.67M$ 53.60M$ 54.94M$ 63.67M$ 67.37M
Stockholders Equity$ 94.44M$ 117.35M$ 138.16M$ 169.37M$ 199.21M
Cash Flow-
Free Cash Flow$ -28.80M$ -26.13M-$ -32.38M$ -30.82M
Operating Cash Flow$ -28.76M$ -26.28M$ -29.11M$ -32.36M$ -36.60M
Investing Cash Flow$ 45.38M$ 19.94M$ -5.49M$ 53.91M$ 19.00M
Financing Cash Flow$ -11.36M$ 1.84M$ 698.63K$ 2.88M$ -424.70K
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

Inovio Pharmaceuticals Debt to Assets

Inovio Pharmaceuticals Cash Flow

Inovio Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis